Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02703805
Other study ID # FFF133486
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 2014
Est. completion date November 2018

Study information

Verified date June 2019
Source McMaster University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Building on an earlier pilot study, this randomized controlled trial will compare the effectiveness of a 12 week community YMCA-based wellness program specifically designed for people with stroke (Fit for Function) to a standard YMCA membership.


Description:

The program will be delivered through a partnership between McMaster University, the YMCA and Hamilton Health Sciences/ the Brant Community Healthcare System/ the Niagara Health System. Participants will exercise three times a week and receive weekly education about how to take care of themselves after a stroke. The YMCA staff who deliver the program will have specialized training about how to help people with a stroke exercise safely and effectively. The hospital within each region will provide specialized on-site physiotherapy consultative support. The comparator standard YMCA membership will include typical sessions with a wellness coach who has basic safety training regarding stroke and exercise.


Recruitment information / eligibility

Status Completed
Enrollment 218
Est. completion date November 2018
Est. primary completion date November 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- diagnosed with stroke

- 18 years of age or older

- community dwelling

- able to walk 10m independently, with or without an assistive device

- medically approved by a physician to participate

- able to tolerate 60 minutes of activity with rest intervals

- able to independently follow instructions

Exclusion Criteria:

- involved in an active rehabilitation program

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Fit For Function Program
A 12-week YMCA-based wellness program for persons with stroke, consisting of 2 group exercise sessions, one gym exercise session and one education session per week with trained instructors
Standard YMCA membership
A 12 week standard YMCA membership.

Locations

Country Name City State
Canada The Brantford Family YMCA Brantford Ontario
Canada Downtown Hamilton YMCA Hamilton Ontario
Canada The Walker Family YMCA St. Catharines Ontario

Sponsors (7)

Lead Sponsor Collaborator
McMaster University Brant Community Healthcare System, Canadian Institutes of Health Research (CIHR), Hamilton Health Sciences Corporation, Niagara Health System, YMCA of Hamilton/Burlington/Brant, YMCA of Niagara

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in the Reintegration to Normal Living Index (RNL) from baseline This measure assesses the degree to which individuals who have experienced traumatic or incapacitating illness achieve reintegration into normal social activities. baseline, 12 weeks, 24 weeks
Secondary Change in The Rapid Assessment of Physical Activity (RAPA) score from baseline This is a 9-item measure that assesses frequency and intensity of aerobic physical activity and frequency of strengthening and flexibility exercises. baseline, 12 weeks, 24 weeks
Secondary Change in The Short Portable Performance Tests (SPPT) score from baseline This test is used to quantify lower extremity function by evaluating the time to walk 8 feet, standing balance and repeated chair stands. baseline, 12 weeks, 24 weeks
Secondary Change in The Six Minute Walk Test (6MWT) from baseline This test is an indicator of exercise capacity and measures the distance walked in 6 minutes. baseline, 12 weeks, 24 weeks
Secondary Change in Strength: Grip and Knee extension from baseline Hand-held dynamometry will measure the average strength of three trials. baseline, 12 weeks, 24 weeks
Secondary Change in The EQ-5D score from baseline This is a generic utility-based health related quality of life questionnaire. baseline, 12 weeks, 24 weeks
Secondary Change in The Patient Activation Measure (PAM) score from baseline This is a 13-item measure of the patient's level of knowledge, skill and confidence for self-management. baseline, 12 weeks, 24 weeks
Secondary Change in The Body Mass Index (BMI) score from baseline The BMI will be calculated from measurements of body mass and height as an indicator of cardiovascular health. baseline, 12 weeks, 24 weeks
Secondary Change in Blood lipid levels from baseline 12 hour fasting levels of lipids will be used as an indicator of cardiovascular health. baseline, 12 weeks, 24 weeks
Secondary Change in blood glucose levels from baseline 12 hour fasting levels of glucose in blood will be used as an indicator of cardiovascular health. baseline, 12 weeks, 24 weeks
Secondary Change in blood inflammatory markers from baseline 12 hour fasting levels of inflammatory markers in blood will be used as an indicator of cardiovascular health. baseline, 12 weeks, 24 weeks
Secondary Healthcare Utilization Questionnaire An indicator of healthcare resource utilization (hospitalizations, medical appointments and investigations, medication use) for economic analysis. 0- 24 weeks
See also
  Status Clinical Trial Phase
Completed NCT05477238 - Oxygen Consumption in Post-stroke Patients During Various Walking Activities Compared to Healthy Controls N/A
Completed NCT00046293 - ReoPro and Retavase to Treat Acute Stroke Phase 2
Completed NCT04584645 - A Digital Flu Intervention for People With Cardiovascular Conditions N/A
Completed NCT01116544 - Treatment of Chronic Stroke With AMES + EMG Biofeedback N/A
Withdrawn NCT04991038 - Clinical Investigation to Compare Safety and Efficacy of DAISE and Stent Retrievers for Thrombectomy In Acute Ischemic Stroke Patients N/A
Active, not recruiting NCT02563886 - Electrically Assisted Movement Therapy N/A
Recruiting NCT02446730 - Efficacy and Safety of BiomatrixTM Stent and 5mg-Maintenance Dose of Prasugrel in Patients With Acute Coronary Syndrome Phase 4
Completed NCT02141932 - Pocket-size Cardiovascular Ultrasound in Stroke N/A
Completed NCT01915368 - Determining Optimal Post-Stroke Exercise (DOSE) N/A
Recruiting NCT02557737 - Botulinim Toxin Type A Injections by Different Guidance in Stroke Patients With Spasticity on Upper Extremities Phase 3
Recruiting NCT01769326 - Influence of Timing on Motor Learning N/A
Terminated NCT01705353 - The Role of HMGB-1 in Chronic Stroke N/A
Completed NCT01423201 - Transient Ischemic Attack (TIA) Triage and Evaluation of Stroke Risk
Completed NCT01182818 - Fabry and Stroke Epidemiological Protocol (FASEP): Risk Factors In Ischemic Stroke Patients With Fabry Disease N/A
Completed NCT01656876 - The Effects of Mirror Therapy on Upper Extremity in Stroke Patients N/A
Completed NCT00542256 - tDCS and Physical Therapy in Stroke N/A
Withdrawn NCT00573092 - Analyzing Gene Regions That May Interact With the Effectiveness of High Blood Pressure Drugs N/A
Completed NCT00377689 - Evaluation of an Intervention Program Targeted at Improving Balance and Functional Skills After Stroke Phase 2
Recruiting NCT00166751 - Sonographic Assessment of Laryngeal Elevation N/A
Completed NCT00149435 - Cardiovascular Health Study (CHS) Events Follow-up Study